Sign in

CIK 0001720893

  • Non-accelerated filer
  • Smaller reporting company

BioXcel Therapeutics, Inc.

Sign in to watch
Ticker
BTAIQ
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821386754
Phone
+1 203-643-8060
Business address
555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
  1. 4/A Exercise or conversion Director acquired 27,089 shares (option exercise)
  2. 4 Exercise or conversion Director acquired 27,089 shares (option exercise)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Planned sale Chief Commercial Officer sold 6,272 shares at $0.55 ($3,450)
  6. 4 Planned sale Rodriguez Javier sold 6,863 shares at $0.55 ($3,775)
  7. 4 Planned sale Chief Scientific Officer sold 7,175 shares at $0.55 ($3,946)
  8. 4 Planned sale Chief Financial Officer sold 7,175 shares at $0.55 ($3,946)
  9. 4 Planned sale O'Neill Vincent sold 5,556 shares at $0.55 ($3,056)
  10. 4 Planned sale Chief Scientific Officer sold 355 shares at $0.69 ($245)
  11. 4 Planned sale CEO and President sold 1,982 shares at an average $0.69 ($1,367)
  12. 4 Planned sale Chief Financial Officer sold 356 shares at $0.69 ($246)
  13. 4 Planned sale Rodriguez Javier sold 345 shares at $0.69 ($238)
  14. 4 Planned sale O'Neill Vincent sold 138 shares at $0.69 ($95)
  15. 4 Planned sale Chief Commercial Officer sold 215 shares at $0.69 ($149)
  16. 4/A Derivatives Options or other derivatives
  17. 4 Planned sale Chief Scientific Officer sold 372 shares at $1.28 ($476)
  18. 4 Planned sale Chief Commercial Officer sold 244 shares at $1.26 ($308)
  19. 4 Planned sale Chief Financial Officer sold 372 shares at $1.26 ($470)
  20. 4 Planned sale Rodriguez Javier sold 361 shares at $1.26 ($456)

Page 5 of 14 · 276 filings